CSIMarket
 


Agilent Technologies inc   (A)
Other Ticker:  
 

Agilent Technologies Inc 's Working Capital Ratio

A's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Agilent Technologies Inc 's Current Assets grew by 3.87 % in the IV Quarter 2023 sequentially, while Current Liabilities decreased, this led to improvement in Agilent Technologies Inc 's Working Capital Ratio to 2.61, Working Capital Ratio remained below Agilent Technologies inc average.

Within Laboratory Analytical Instruments industry 16 other companies have achieved higher Working Capital Ratio than Agilent Technologies Inc in forth quarter 2023. While Working Capital Ratio total ranking has improved so far during the IV Quarter 2023 to 1688, from total ranking in the third quarter 2023 at 2041.

Explain Working Capital Ratio
How much in Current Assets A´s has?
What is the value of A´s Current Liabilities?


A Working Capital Ratio (Oct 31 2023)
IV. Quarter
(Jul 31 2023)
III. Quarter
(Apr 30 2023)
II. Quarter
(Jan 31 2023)
I. Quarter
(Oct 31 2022)
IV. Quarter
Y / Y Current Liabilities Change -13.86 % -7.47 % -8.11 % 22.22 % 8.96 %
Y / Y Current Assets Change 10.8 % 9.21 % 8.4 % 17.39 % -0.55 %
Working Capital Ratio MRQ 2.61 2.29 2.37 2.11 2.03
A's Total Ranking # 1688 # 2041 # 2093 # 1119 # 2431
Seq. Current Liabilities Change -8.92 % 5.64 % -13.95 % 4.03 % -2.16 %
Seq. Current Assets Change 3.87 % 2.05 % -3.16 % 7.94 % 2.38 %



Working Capital Ratio forth quarter 2023 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 17
Healthcare Sector # 648
Overall Market # 1688


Working Capital Ratio Statistics
High Average Low
4.08 2.7 1.53
(Jul 31 2015)   (Oct 31 2019)




Financial Statements
Agilent Technologies Inc 's Current Liabilities $ 1,603 Millions Visit A's Balance sheet
Agilent Technologies Inc 's Current Assets $ 4,186 Millions Visit A's Balance sheet
Source of A's Sales Visit A's Sales by Geography


Cumulative Agilent Technologies Inc 's Working Capital Ratio

A's Working Capital Ratio for the trailling 12 Months

A Working Capital Ratio

(Oct 31 2023)
IV. Quarter
(Jul 31 2023)
III. Quarter
(Apr 30 2023)
II. Quarter
(Jan 31 2023)
I. Quarter
(Oct 31 2022)
IV. Quarter
Y / Y Current Liabilities TTM Growth -13.86 % -7.47 % -8.11 % 22.22 % 8.96 %
Y / Y Current Assets TTM Growth 10.8 % 9.21 % 8.4 % 17.39 % -0.55 %
Working Capital Ratio TTM 2.33 2.19 2.1 2.02 2.04
Total Ranking TTM # 1549 # 1739 # 1954 # 2344 # 2305
Seq. Current Liabilities TTM Growth -8.92 % 5.64 % -13.95 % 4.03 % -2.16 %
Seq. Current Assets TTM Growth 3.87 % 2.05 % -3.16 % 7.94 % 2.38 %


On the trailing twelve months basis A Current Assets increased by 10.8 % in IV Quarter 2023 year on year, while Current Liabilities decreased to $1,603 millions, this led to increase in in Agilent Technologies Inc 's Working Capital Ratio to 2.33, Working Capital Ratio remained below A average.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 29 other companies have achieved higher Working Capital Ratio than Agilent Technologies Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3877 to 3892.

Explain Working Capital Ratio
How much in Current Assets A´s has?
What is the value of A´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 30
Healthcare Sector # 1029
Within the Market # 1688


trailing twelve months Working Capital Ratio Statistics
High Average Low
3.72 2.63 1.71
(June 30. 2015)   (Apr 30 2020)




Companies with similar Working Capital Ratio in the quarter ending Oct 31 2023, within Laboratory Analytical Instruments Industry Working Capital RatioOct 31 2023 MRQ Current AssetsOct 31 2023 MRQ Current Liabilities
Lifeloc Technologies Inc   6.28 $ 6.024  Millions$ 0.959  Millions
Bio rad Laboratories Inc   6.06 $ 3,146.770  Millions$ 519.060  Millions
Reflect Scientific Inc   5.51 $ 2.393  Millions$ 0.434  Millions
10x Genomics Inc   5.37 $ 562.348  Millions$ 104.717  Millions
Pacific Biosciences Of California Inc   4.80 $ 882.297  Millions$ 183.961  Millions
Scientific Industries Inc   3.93 $ 8.572  Millions$ 2.183  Millions
Standard Biotools Inc   3.30 $ 170.741  Millions$ 51.800  Millions
Akoya Biosciences Inc   3.29 $ 116.948  Millions$ 35.523  Millions
Cue Health Inc   3.29 $ 192.239  Millions$ 58.407  Millions
Agilent Technologies inc   2.61 $ 4,186.000  Millions$ 1,603.000  Millions
Bionano Genomics Inc   2.60 $ 104.537  Millions$ 40.194  Millions
Eyepoint Pharmaceuticals Inc   2.35 $ 150.163  Millions$ 63.896  Millions
Kewaunee Scientific Corporation  2.35 $ 90.876  Millions$ 38.732  Millions
Harvard Bioscience Inc  2.09 $ 50.486  Millions$ 24.205  Millions
Revvity Inc   2.01 $ 2,913.237  Millions$ 1,447.845  Millions
Bruker Corporation  1.89 $ 2,029.400  Millions$ 1,072.300  Millions
Illumina Inc   1.69 $ 2,506.000  Millions$ 1,482.000  Millions
Avantor Inc   1.60 $ 2,384.800  Millions$ 1,488.100  Millions
Mettler toledo International Inc   1.34 $ 1,196.912  Millions$ 891.340  Millions
Accelerate Diagnostics Inc   0.86 $ 32.443  Millions$ 37.786  Millions
Precipio inc   0.85 $ 4.309  Millions$ 5.060  Millions
Thermogenesis Holdings Inc   0.78 $ 6.925  Millions$ 8.890  Millions

Date modified: 2023-12-21T15:22:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com